|
2020 Conference Publication Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomasThuzar, Moe, Lo, Yu-Chin, Guo, Zeng, Inder, Warrick J. and Stowasser, Michael (2020). Relationship between the hypothalmic-pituitary-adrenocortical axis activity and the characteristics of aldosterone-producing adenomas. 22nd European Congress of Endocrinology, Online, 5 - 9 September 2020. Bristol, United Kingdom: Bioscientifica. doi: 10.1530/endoabs.70.aep47 |
|
2019 Conference Publication Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression testThuzar, M., Young, K., Ahmed, A., Wolley, M., Guo, Z., Ward, G., McWhinney, B., Ungerer, J. and Stowasser, M. (2019). Defining the optimal cut-off plasma aldosterone level measured by immunoassay for the diagnosis of primary aldosteronism using seated salines suppression test. 29th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Milan, Italy, 21-24 June 2019. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000570272.55373.54 |
|
2018 Conference Publication Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over studyThuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2018). Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY. |
|
2017 Conference Publication Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled studyThuzar, Moe, Law, W. Phillip, Ratnasingam, Jeyakantha, Franklin, Michael, Dimeski, Goce and Ho, Ken K. Y. (2017). Effect of formoterol, a selective beta(2)-adrenergic agonist, on brown adipose tissue function in humans: a double-blind placebo controlled study. HOBOKEN: WILEY-BLACKWELL. |
